DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Gaal LF Van, Rissanen AM, Scheen AJ. et al.
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.
Lancet 2005; 365: 1389-1397
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.